Literature DB >> 19169857

RNA interference inhibits yellow fever virus replication in vitro and in vivo.

Carolina C Pacca1, Adriana A Severino, Adriano Mondini, Paula Rahal, Solange G P D'avila, José Antonio Cordeiro, Mara Correa Lelles Nogueira, Roberta V M Bronzoni, Maurício L Nogueira.   

Abstract

RNA interference (RNAi) is a process that is induced by double stranded RNA and involves the degradation of specific sequences of mRNA in the cytoplasm of the eukaryotic cells. It has been used as an antiviral tool against many viruses, including flaviviruses. The genus Flavivirus contains the most important arboviruses in the world, i.e., dengue (DENV) and yellow fever (YFV). In our study, we investigated the in vitro and in vivo effect of RNAi against YFV. Using stable cell lines that expressed RNAi against YFV, the cell lines were able to inhibit as much as 97% of the viral replication. Two constructions (one against NS1 and the other against E region of YFV genome) were able to protect the adult Balb/c mice against YFV challenge. The histopathologic analysis demonstrated an important protection of the central nervous system by RNAi after 10 days of viral challenge. Our data suggests that RNAi is a potential viable therapeutic weapon against yellow fever.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19169857     DOI: 10.1007/s11262-009-0328-3

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  32 in total

Review 1.  The Brazilian flaviviruses.

Authors:  L T Figueiredo
Journal:  Microbes Infect       Date:  2000-11       Impact factor: 2.700

2.  Enhanced gene silencing by the application of multiple specific small interfering RNAs.

Authors:  Jingmin Ji; Marion Wernli; Thomas Klimkait; Peter Erb
Journal:  FEBS Lett       Date:  2003-09-25       Impact factor: 4.124

Review 3.  Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.

Authors:  Derek M Dykxhoorn; Judy Lieberman
Journal:  Annu Rev Biomed Eng       Date:  2006       Impact factor: 9.590

4.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

5.  Engineered resistance in Aedes aegypti to a West African and a South American strain of yellow fever virus.

Authors:  S Higgs; J O Rayner; K E Olson; B S Davis; B J Beaty; C D Blair
Journal:  Am J Trop Med Hyg       Date:  1998-05       Impact factor: 2.345

Review 6.  Yellow fever: an update.

Authors:  T P Monath
Journal:  Lancet Infect Dis       Date:  2001-08       Impact factor: 25.071

7.  Using RNA interference to develop dengue virus resistance in genetically modified Aedes aegypti.

Authors:  Emily A Travanty; Zach N Adelman; Alexander W E Franz; Kimberly M Keene; Barry J Beaty; Carol D Blair; Anthony A James; Ken E Olson
Journal:  Insect Biochem Mol Biol       Date:  2004-07       Impact factor: 4.714

8.  Suppression of HIV replication using RNA interference against HIV-1 integrase.

Authors:  Tat San Lau; Yonggang Li; Masanori Kameoka; Tzi Bun Ng; David Chi Cheong Wan
Journal:  FEBS Lett       Date:  2007-06-15       Impact factor: 4.124

9.  Interferon action on Mayaro virus replication.

Authors:  M C Rebello; M E Fonseca; J O Marinho; M A Rebello
Journal:  Acta Virol       Date:  1993-08       Impact factor: 1.162

10.  Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region.

Authors:  Joyce A Wilson; Christopher D Richardson
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

View more
  16 in total

Review 1.  Experimental therapies for yellow fever.

Authors:  Justin G Julander
Journal:  Antiviral Res       Date:  2012-12-10       Impact factor: 5.970

Review 2.  Novel approaches to flavivirus drug discovery.

Authors:  Carolyn Botting; Richard J Kuhn
Journal:  Expert Opin Drug Discov       Date:  2012-03-22       Impact factor: 6.098

3.  Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence.

Authors:  David A Stein; Stuart T Perry; Michael D Buck; Christopher S Oehmen; Matthew A Fischer; Elizabeth Poore; Jessica L Smith; Alissa M Lancaster; Alec J Hirsch; Mark K Slifka; Jay A Nelson; Sujan Shresta; Klaus Früh
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

4.  RNAi effects on actin mRNAs in Homalodisca vitripennis cells.

Authors:  Cristina Rosa; Shizuo G Kamita; Haley Dequine; Ha Wuriyanghan; John A Lindbo; Bryce W Falk
Journal:  J RNAi Gene Silencing       Date:  2010-04-15

5.  Viral infection resistance conferred on mice by siRNA transgenesis.

Authors:  Nathalie Daniel-Carlier; Ashraf Sawafta; Bruno Passet; Dominique Thépot; Mathieu Leroux-Coyau; François Lefèvre; Louis-Marie Houdebine; Geneviève Jolivet
Journal:  Transgenic Res       Date:  2012-09-09       Impact factor: 2.788

6.  The eukaryotic translation initiation factor 3 subunit L protein interacts with Flavivirus NS5 and may modulate yellow fever virus replication.

Authors:  Ana Ts Morais; Ana Cb Terzian; Danilo Vb Duarte; Roberta Vm Bronzoni; Maria Cfs Madrid; Arieli F Gavioli; Laura Hvg Gil; Amanda G Oliveira; Cleslei F Zanelli; Sandro R Valentini; Paula Rahal; Mauricio L Nogueira
Journal:  Virol J       Date:  2013-06-22       Impact factor: 4.099

7.  Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA.

Authors:  Usman Ali Ashfaq; Muhammad Ansar; Muhammad Tahir Sarwar; Tariq Javed; Sidra Rehman; Sheikh Riazuddin
Journal:  Virol J       Date:  2011-03-10       Impact factor: 4.099

8.  Identification of an effective siRNA target site and functional regulatory elements, within the hepatitis B virus posttranscriptional regulatory element.

Authors:  Nattanan Panjaworayan; Sunchai Payungporn; Yong Poovorawan; Chris M Brown
Journal:  Virol J       Date:  2010-09-08       Impact factor: 4.099

9.  Protection against lethal Marburg virus infection mediated by lipid encapsulated small interfering RNA.

Authors:  Raul Ursic-Bedoya; Chad E Mire; Marjorie Robbins; Joan B Geisbert; Adam Judge; Ian MacLachlan; Thomas W Geisbert
Journal:  J Infect Dis       Date:  2013-08-29       Impact factor: 5.226

10.  The RNAi pathway plays a small part in Wolbachia-mediated blocking of dengue virus in mosquito cells.

Authors:  Gerard Terradas; D Albert Joubert; Elizabeth A McGraw
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.